 |
| Respiratory Inhalers Market |
Respiratory inhalers are medical devices used for the delivery of medication to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Common respiratory inhalers include dry powder inhalers (DPI), metered dose inhalers (MDI), and soft mist inhalers. Respiratory inhalers provide quick relief and are easy to use, which makes them a preferred mode of medication delivery for respiratory diseases. The global Respiratory Inhalers Market is estimated to be valued at US$ 29.55 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased demand for preventive care has accelerated the growth of the
respiratory inhalers market. Growing health awareness has led more people to
opt for preventive medication to control their respiratory conditions. Using
inhalers as a maintenance therapy helps manage the symptoms of respiratory
diseases and prevent exacerbations. The availability of several variants of
inhalers including dry powder, metered dose, and soft mist inhalers provide
customized treatment options for individual needs and preferences. Additionally,
the ease of use, portability, and self-administration features of inhalers make
them a suitable option for overall respiratory health maintenance. This rising
preference for preventive medication management through inhalers is a key trend
fueling the market growth.
Segment Analysis
Dry Powder Inhalers (DPI) dominate the respiratory inhalers market currently,
accounting for nearly 50% of the market share. These are more convenient to use
compared to metered dose inhalers as patients do not need to coordinate
spraying and inhaling. DPI formulations are powder based and require less
energy to disperse the drug. Most popular drugs for asthma and COPD like
salbutamol and fluticasone are available in DPI formulations. Metered Dose
Inhalers follow DPIs in terms of market share around 30%. MDIs containing
hydrofluoroalkane (HFA) propellants ensure efficient delivery of drug to lungs.
Soft Mist Inhalers are a new platform that account for 15% share. They generate
a mist of large particles for maximum drug deposition in deep lungs.
Key Takeaways
The global Respiratory
Inhalers Market Share is expected to witness high growth driven by
rising pollution levels, growing elderly population and technological
advancements. North America currently dominates with a share of over 35% owing
to high adoption of inhalers and presence of major players. However, Asia
Pacific is emerging as the fastest growing region supported by increasing
healthcare expenditure, growing awareness and large patient pool.
Regional analysis: Asia Pacific is poised to grow at a CAGR of over 8% during
the forecast period driven by rising air pollution and prevalence of
respiratory diseases like asthma. China and India are the major contributors to
the region's growth. Governments are focusing on improving access to inhalers
in rural areas.
Key players: Key players operating in the Respiratory Inhalers market are
Unilever, Procter & Gamble, Reckitt Benckiser, Henkel AG & Co. KGaA,
Church & Dwight Co. Inc., Wipro Enterprises Limited, Colgate-Palmolive
Company, C.Johnson & Son Inc.
For more insights, read- https://www.ukwebwire.com/respiratory-inhalers-market-trends-size-and-share-analysis/
Comments
Post a Comment